20% Discount on all orders above $200

Cagrilintide 10mg

Long-Acting Amylin Analogue / Dual-Agonist Component

$95.00$70.00

Grade: Research Grade / Analytical Standard

Purity: ≥99% (HPLC Verified)

Format: Lyophilized (Freeze-Dried) Powder

Unit Size: 10 mg

Product Overview

Cagrilintide 10mg is a non-selective, long-acting synthetic amylin receptor agonist engineered for cutting-edge laboratory research into metabolic control, satiety signaling, and body weight regulation. As an analogue of human amylin, Cagrilintide acts on AMY (amylin) receptors and CTR (calcitonin) receptors, serving as a key compound in investigating central appetite suppression mechanisms and delayed gastric emptying kinetics.

This 10mg high-yield format provides research facilities with an optimal volume for conducting multi-run metabolic assays, central nervous system signaling evaluations, and co-administration research alongside incretin mimetics (e.g., Semaglutide).

Key Research Features & Highlights

  • Dual AMY/CTR Receptor Agonism: Engages both amylin and calcitonin receptor complexes to regulate central satiety pathways and energy intake signaling.

  • Engineered Extended Stability: Features structural modifications—including fatty acid acylation—that extend plasma half-life and enhance enzymatic stability in analytical models.

  • Incretin Co-Agonism Component: Widely referenced in literature as a foundational component for evaluating non-incretin / GLP-1 additive pathways in metabolic research.

  • Analytical Grade Purity (≥99%): Standardized and batch-tested using High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) to guarantee high experimental repeatability.

Primary Applications in Laboratory Research

  • Central Satiety & Appetite Pathways: Studying hypothalamic and hindbrain signaling mechanisms regulating food intake and satiety.

  • Gastric Motility Kinetics: Investigating delayed gastric emptying rates and postprandial glucose regulation.

  • Additive Metabolic Synergies: Evaluating co-agonist kinetics when combined with GLP-1 receptor agonists (e.g., Semaglutide) in dual-targeting metabolic models.

  • Glucagon Suppression Mechanics: Researching pancreatic hormone balance and glucose-dependent glucagon inhibition.

Product Specifications

Attribute

Specification

Active Compound

Cagrilintide (NN9838)

Net Quantity

10 mg

Form

Lyophilized White Powder

CAS Number

1415456-99-3

Molecular Mass

~4049.60 g/mol

Purity Standard

≥99% (HPLC verified)

Solubility

Soluble in Bacteriostatic Water or Sterile Deionized Water

Storage & Handling Protocols

  • Unreconstituted (Lyophilized): Store frozen at or below -20°C in a dry, dark environment protected from heat and moisture.

  • Reconstituted Solution: Maintain at 2°C – 8°C following dilution with sterile solvent and utilize within 30 days. Avoid repeated freeze-thaw cycles.

Mandatory Research & Legal Disclaimer

FOR LABORATORY RESEARCH USE ONLY. This compound is supplied strictly for in vitro laboratory research, educational, and analytical evaluation. It is not approved for human or animal consumption, medical therapy, diagnostic procedures, or commercial formulation.